Literature DB >> 6817133

[Co-dergocrinmesylate in elderly hypertensive patients].

K D Bock, D Welzel, H J Dennler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6817133

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN： 0341-3098


× No keyword cloud information.
  5 in total

1.  Clinical pharmacokinetics of the nifedipine/co-dergocrine combination in impaired liver and renal function.

Authors:  W Kirch; A Nokhodian; A Halabi; G Weidinger
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jan-Mar       Impact factor: 2.441

2.  Cardiovascular regulation and lipoprotein profile during administration of co-dergocrine in essential hypertension.

Authors:  D E Uehlinger; P Weidmann; M P Gnaedinger
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Steady state bioavailability of a new oral formulation of Hydergine in geriatric patients.

Authors:  F Sörgel; E Abisch; H J Dennler; E Lang
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  The absolute systemic availability of a new oral formulation of co-dergocrine in healthy subjects.

Authors:  P Dominiak; J Grevel; E Abisch; H Grobecker; H J Dennler; D Welzel
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Cardiovascular regulation during administration of co-dergocrine to normal subjects.

Authors:  A Gerber; P Weidmann; K Laederach
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.